Trinity Biotech (TRIB) FCF Margin (2009 - 2024)
Trinity Biotech (TRIB) posted FCF Margin of 23.59% for Q4 2024, up 465.55% sequentially from 4.17% in Q4 2023, and up 1942.0% YoY from 1.16% in Q1 2024.
Trinity Biotech (TRIB) FCF Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has reported FCF Margin for 14 years, with the latest figure at 23.59% in Q4 2024.
- Quarterly FCF Margin rose 1942.0% year-over-year to 23.59% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 6.08% (up 487.0% YoY) and the FY2025 annual result came in at 13.74%, down 463.0% from the prior year.
- FCF Margin rose to 23.59% in Q4 2024 per TRIB's latest filing, from 4.17% in the prior quarter.
- Over five years, FCF Margin peaked at 23.59% in Q4 2024 and troughed at 0.0% in Q2 2022.
- A 4-year average of 8.9% and a median of 3.11% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2024: FCF Margin tumbled 1339 bps in 2023, then jumped 1942 bps in 2024.
- Over 4 years, FCF Margin stood at 22.94% in 2021, then retreated by 23 bps to 17.56% in 2022, then slumped by 76 bps to 4.17% in 2023, then soared by 466 bps to 23.59% in 2024.
- According to Business Quant data, FCF Margin over the past three periods registered 23.59%, 4.17%, and 0.87% for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.73% |
| 10 | Trinity Biotech | 6.45 Mn | 1.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 23.59% |
| Dec 31, 2023 | 4.17% |
| Sep 30, 2023 | 0.87% |
| Dec 31, 2022 | 17.56% |
| Sep 30, 2022 | 2.04% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 22.94% |
| Jun 30, 2021 | 0.00% |
| Jun 30, 2018 | 6.95% |
| Jun 30, 2017 | 13.25% |
| Dec 31, 2016 | -11.87% |
| Dec 31, 2015 | -11.34% |
| Dec 31, 2014 | -13.74% |
| Dec 31, 2013 | -11.71% |
| Dec 31, 2012 | -11.75% |
| Dec 31, 2011 | -13.26% |
| Dec 31, 2010 | -16.68% |
| Sep 30, 2010 | 8.08% |
| Jun 30, 2010 | 4.91% |
| Mar 31, 2010 | 8.01% |